DESIGNER BABIES: SCIENCE OR SPECULATION?

“𝓘𝓽’𝓼 𝓸𝓷𝓮 𝓽𝓱𝓲𝓷𝓰 𝓽𝓸 𝓾𝓼𝓮 𝓰𝓮𝓷𝓮𝓽𝓲𝓬𝓼 𝓽𝓸 𝓬𝓾𝓻𝓮 𝓭𝓲𝓼𝓮𝓪𝓼𝓮; 𝓲𝓽’𝓼 𝓪𝓷𝓸𝓽𝓱𝓮𝓻 𝓽𝓸 𝓾𝓼𝓮 𝓲𝓽 𝓽𝓸 𝓹𝓲𝓬𝓴 𝓪 𝓬𝓱𝓲𝓵𝓭’𝓼 𝓮𝔂𝓮 𝓬𝓸𝓵𝓸𝓻 𝓸𝓻 𝓘𝓠. 𝓣𝓱𝓪𝓽’𝓼 𝓷𝓸𝓽 𝓶𝓮𝓭𝓲𝓬𝓲𝓷𝓮, 𝓽𝓱𝓪𝓽’𝓼 𝓼𝓸𝓬𝓲𝓪𝓵 𝓮𝓷𝓰𝓲𝓷𝓮𝓮𝓻𝓲𝓷𝓰.” — Dr. Marcy Darnovsky

🧬 The rise of CRISPR and advanced gene-editing tools has made what once sounded like science fiction a real possibility; babies with selected traits. From preventing hereditary diseases to enhancing intelligence or appearance, the idea of designer babies has shifted from imagination to lab reality.

          𝓑𝓾𝓽 𝔀𝓲𝓽𝓱 𝓰𝓻𝓮𝓪𝓽 𝓹𝓸𝔀𝓮𝓻 𝓬𝓸𝓶𝓮𝓼 𝓹𝓻𝓸𝓯𝓸𝓾𝓷𝓭 𝓮𝓽𝓱𝓲𝓬𝓪𝓵 𝓭𝓲𝓵𝓮𝓶𝓶𝓪𝓼.

          🔹 On one hand, gene editing offers tremendous potential; eradicating inherited disorders and improving quality of life for future generations. The medical promise is undeniable.
          🔹 On the other, the ethical costs loom large. What happens when genetics becomes a marketplace for perfection? Critics warn of widening inequalities, loss of genetic diversity, and even a return to eugenic thinking. Who decides what traits are “worthy”? And what are the societal implications for those born without enhancements?
          🔹In short, designer babies aren’t just a question of can we; they force us to ask should we.

⚠️ In an Oystershell, as this frontier unfolds, the need for multidisciplinary dialogue is urgent. Science, ethics, and policy must evolve together to ensure innovation does not outpace responsibility.

Abubakar Abubakar ✍🏻

• Doudna, J. A., & Charpentier, E. (2014).
"The new frontier of genome engineering with CRISPR-Cas9."
Science, 346(6213), 1258096.

• Lanphier, E., Urnov, F., Haecker, S. E., Werner, M., & Smolenski, J. (2015).
"Don't edit the human germ line."
Nature, 519(7544), 410–411.

• Savulescu, J., Pugh, J., Douglas, T., & Gyngell, C. (2015).
"The moral imperative to continue gene editing resear

Popular posts from this blog

FINDING LAUGHTER IN UNEXPECTED MOMENTS: A LESSON IN BEING PREPARED

Image
Today's blog is about an experience I had while visiting a religious site on the outskirts of town. As I was leaving, a lady approached me, asking for a donation. Unfortunately, I wasn’t carrying any cash at the time, so I asked her, "Do you use UPI by any chance?" She burst into laughter 😄, smiling at my unexpected question. The lesson here is that we should always be prepared with alternatives, as they might be a way to help others.  At the very least, I managed to put a smile on her face, which made the encounter worthwhile 😊
Read more

CHROMOSOMAL MICROARRAY VS. WHOLE EXOME SEQUENCING

Image
“𝓜𝓲𝓬𝓻𝓸𝓪𝓻𝓻𝓪𝔂𝓼 𝓱𝓮𝓵𝓹 𝓾𝓼 𝓯𝓲𝓷𝓭 𝓶𝓲𝓼𝓼𝓲𝓷𝓰 𝓸𝓻 𝓮𝔁𝓽𝓻𝓪 𝓬𝓱𝓻𝓸𝓶𝓸𝓼𝓸𝓶𝓪𝓵 𝓹𝓲𝓮𝓬𝓮𝓼; 𝓦𝓔𝓢 𝓽𝓪𝓴𝓮𝓼 𝓾𝓼 𝓭𝓮𝓮𝓹𝓮𝓻, 𝓲𝓷𝓽𝓸 𝓽𝓱𝓮 𝓬𝓸𝓭𝓲𝓷𝓰 𝓻𝓮𝓰𝓲𝓸𝓷𝓼 𝔀𝓱𝓮𝓻𝓮 𝓻𝓪𝓻𝓮 𝓿𝓪𝓻𝓲𝓪𝓷𝓽𝓼 𝓱𝓲𝓭𝓮.” — Ellen Matloff 🧬 Chromosomal Microarray (CMA) and Whole Exome Sequencing (WES) are cornerstones of modern genomic diagnostics. Each offers unique insights: CMA identifies large-scale structural changes like copy number variations (CNVs), while WES investigates the exome; the protein-coding portion where most pathogenic mutations reside. 🔹 CMA is a first-line tool for neurodevelopmental disorders, intellectual disability, and congenital anomalies. It scans for chromosomal imbalances missed by karyotyping, offering ~15–20% diagnostic yield in such cases. Its speed and cost-effectiveness make it a go-to for initial evaluations. 🔹 WES, by contrast, dives into the exonic 1–2% of the genome that harbors ~85% of known disease-causing ...
Read more